Sullivan Alexander E, Beckman Joshua A
Division of Cardiology, Vanderbilt University Medical Center, Nashville, Tennessee.
Semin Intervent Radiol. 2023 Jun 16;40(2):119-128. doi: 10.1055/s-0043-57257. eCollection 2023 Apr.
Peripheral artery disease (PAD) is a common type of atherosclerotic disease of the lower extremities associated with reduced quality of life and ambulatory capacity. Major adverse cardiovascular events and limb amputations are the leading cause of morbidity and mortality in this population. Optimal medical therapy is therefore critical in these patients to prevent adverse events. Risk factor modifications, including blood pressure control and smoking cessation, in addition to antithrombotic agents, peripheral vasodilators, and supervised exercise therapy are key pillars of medical therapy. Revascularization procedures represent key touch points between patients and health care providers and serve as opportunities to optimize medical therapy and improve long-term patency rates and outcomes. This review summarizes the aspects of medical therapy that all providers should be familiar with when caring for patients with PAD in the peri-revascularization period.
外周动脉疾病(PAD)是一种常见的下肢动脉粥样硬化疾病,与生活质量下降和行走能力降低相关。主要不良心血管事件和肢体截肢是该人群发病和死亡的主要原因。因此,最佳药物治疗对于预防这些患者的不良事件至关重要。除抗血栓药物、外周血管扩张剂和监督下的运动疗法外,包括血压控制和戒烟在内的危险因素调整是药物治疗的关键支柱。血管重建手术是患者与医疗服务提供者之间的关键接触点,也是优化药物治疗、提高长期通畅率和改善治疗效果的机会。本综述总结了在血管重建围手术期护理PAD患者时所有医疗服务提供者都应熟悉的药物治疗方面。